ACAT2 and neoplasm: In addition to the direct antigen-specific killing effect, ACTL can also reverse the immunosuppressive state of the TME through microenvironment remodeling, establishing long-term immune surveillance to prevent clonal escape caused by tumor heterogeneity (7, 18–21).